HTT and Huntington disease: At present, a number of knock-in and transgenic mouse models, expressing the N-terminal fragment of HD exon 1 (e.g. R6/2 mice [12]) or the full-length endogenous / human mutant htt (such as the BACHD mice [13]) provide ample opportunities to study the chronically progressing phenotype of the disease [14].